Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

INDUSTRY 58OTHER 48NIH 9NETWORK 4OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Esophageal Neoplasms 7Breast Neoplasms 6Stomach Neoplasms 4Uterine Cervical Neoplasms 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Thymoma 1Small Cell Lung Carcinoma 1Recurrence 1Ovarian Neoplasms 1Neoplasms, Germ Cell and Embryonal 1Neoplasm Metastasis 1Fibrosis Of Extraocular Muscles, Congenital, 3A, with or without Extraocular Involvement 1Fallopian Tube Neoplasms 1Esophageal Squamous Cell Carcinoma 1Endometrial Neoplasms 1EGFR Positive Non-small Cell Lung Cancer 1Carcinoma, Ovarian Epithelial 1Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction 1

Interventions

Irinotecan 6S 1 (combination) 4Oxaliplatin 3palbociclib 2durvalumab 2Tamoxifen 2Radiation 2Erlotinib Hydrochloride 2Cetuximab 2Capecitabine 2tremelimumab 1trametinib 1titanium silicide 1sintilimab 1olaparib 1nilotinib 1glasdegib 1genexol-PM 1futibatinib 1dabrafenib 1ceritinib 1capmatinib 1anlotinib 1Temozolomide 1Talc 1Surgical Procedures, Operative 1Radiosurgery 1Pancreatectomy 1Paclitaxel 1Methylene Blue 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Neoplasm Metastasis × Paclitaxel × Clear all
NCT01169870 2012-01-04

Genexol-PM Versus Paclitaxel in Anthracycline-pretreated Metastatic Breast Cancer Patients

National Cancer Center, Korea

Phase 2 Withdrawn
Breast

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡